Related Experiment Video
Updated: Aug 30, 2026

Simple and Fast Rolling Circle Amplification-Based Detection of Topoisomerase 1 Activity in Crude Biological Samples
Published on: December 2, 2022
Position-specific trapping of topoisomerase II by benzo[a]pyrene diol epoxide adducts: implications for interactions
Qasim A Khan1, Glenda Kohlhagen, Richard Marshall
1Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health/DHHS, Building 37, Bethesda, MD 20892, USA.
Abstract:
DNA topoisomerase II (Top2) is the target of some of the most effective anticancer DNA intercalators. To determine the effect of intercalating ligands at defined positions relative to a known DNA cleavage site for human Top2alpha, we synthesized oligodeoxynucleotides containing single trans-opened benzo[a]pyrene 7,8-diol 9,10-epoxide (DE) deoxyadenosine (dA) adducts of known absolute configuration, placed at specific positions in a duplex sequence containing staggered Top2 cleavage sites on both strands. Because the orientations of the intercalated hydrocarbon are known from NMR solution structures of duplex oligonucleotides containing these dA adducts, a detailed analysis of the relationship between the position of intercalation and trapping of Top2 is possible. Our findings demonstrate that (i) Top2 cleavage complexes are trapped by intercalation of the hydrocarbon at either of the staggered cleavage sites or immediately adjacent to the base pairs flanking the cleavage sites within the stagger; (ii) both concerted and nonconcerted cleavage by both subunits of a Top2 homodimer were detected depending on the position of the benzo[a]pyrene DE dA adduct; and (iii) intercalation immediately outside of the staggered Top2 cleavage site, and to a lesser extent in the middle of the stagger, prevents Top2 from cleaving DNA at this site, consistent with the effect of some intercalators as suppressors of Top2-mediated DNA cleavage. These results identify specific binding sites for intercalators that result in trapping of Top2. Such poisoning of Top2 by bulky polycyclic aromatic hydrocarbon DE adducts constitutes a potential mechanism for their carcinogenic activity.
Insights
DNA topoisomerase II (Top2) is targeted by anticancer drugs. Intercalating polycyclic aromatic hydrocarbons near Top2 cleavage sites can trap the enzyme, potentially explaining their carcinogenicity.
Area of Science:
- Biochemistry
- Molecular Biology
- Medicinal Chemistry
Background:
- DNA topoisomerase II (Top2) is a crucial enzyme in DNA replication and transcription.
- Top2 is a validated target for numerous anticancer drugs, particularly DNA intercalators.
- Understanding drug-DNA-enzyme interactions is key to developing effective cancer therapies.
Purpose of the Study:
- To investigate how intercalating ligands at specific positions affect human Topoisomerase II alpha (Top2α) DNA cleavage.
- To correlate the position and orientation of benzo[a]pyrene DE dA adducts with Top2 trapping.
- To elucidate the mechanism of Top2 poisoning by bulky polycyclic aromatic hydrocarbons.
Main Methods:
- Synthesis of oligodeoxynucleotides with specific benzo[a]pyrene DE dA adducts.
- NMR structural analysis of DNA-ligand complexes.
- Assays to detect Top2 cleavage complex formation and DNA cleavage activity.
Main Results:
- Top2 cleavage complexes are trapped by intercalation at or near staggered Top2 cleavage sites.
- The position of the adduct influences whether Top2 cleavage is concerted or non-concerted.
- Intercalation outside the cleavage site suppresses Top2-mediated DNA cleavage.
Conclusions:
- Specific binding sites for intercalators that trap Top2 have been identified.
- Top2 poisoning by bulky polycyclic aromatic hydrocarbon DE adducts is a potential mechanism for their carcinogenic activity.
- These findings provide insights into the design of Top2-targeting anticancer agents and understanding chemical carcinogenesis.
More Related Videos
Related Concept Videos
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Inhibitors of Bacterial DNA Synthesis
Drugs that Stabilize Microtubules
π Electron Effects on Chemical Shift: Aromatic and Antiaromatic Compounds
Drugs that Destabilize Microtubules
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...

